Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
Paullones constitute a new family of benzazepinones with promising antitumoral properties. They were recently described as potent, ATP‐competitive, inhibitors of the cell cycle regulating cyclin‐dependent kinases (CDKs). We here report that paullones also act as very potent inhibitors of glycogen synthase kinase‐3β (GSK‐3β) (IC 50: 4–80 n m) and the neuronal CDK5/p25 (IC 50: 20–200 n m). These two enzymes are responsible for most of the hyperphosphorylation of the microtubule‐binding protein tau, a feature observed in the brains of patients with Alzheimer’s disease and other neurodegenerative ‘taupathies’. Alsterpaullone, the most active paullone, was demonstrated to act by competing with ATP for binding to GSK‐3β. Alsterpaullone inhibits the phosphorylation of tau in vivo at sites which are typically phosphorylated by GSK‐3β in Alzheimer’s disease. Alsterpaullone also inhibits the CDK5/p25‐dependent phosphorylation of DARPP‐32 in mouse striatum slices in vitro. This dual specificity of paullones may turn these compounds into very useful tools for the study and possibly treatment of neurodegenerative and proliferative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“b-catenin associates with transcription factors of the LEF-1 family to activate the expression of specific genes, in particular the cyclin D1 gene [90, 91 ].”
BackgroundHanks, S. K., & Hunter, T. R. (1995) · PubMed · Cited by 2,518
The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1
Hanks, S. K., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768349 · Cited by 2,318
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“GSK-3b appears to participate to control cyclin D1 levels: (a) GSK-3b phosphorylates cyclin D1 on Thr286 and this leads to its redistribution from the nucleus to the cytoplasm and to its proteolytic degradation [11].”
BackgroundConversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
Uber eine eigenartige Erkrankung der Hirnrinde
Alzheimer, A. (1907) · Medical Entomology and Zoology · Cited by 1,503
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Self-citationLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 1×
“In contrast, no GSK-3 inhibitors have been reported besides lithium [68,69], which is not very potent and is unlikely to be very selective, and bisindolylmaleimide I and IV [70], which are not very selective.”
BackgroundYost, C., Torres, M., Miller, J. R., Huang, E., Kimelman, D., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.12.1443 · Cited by 1,165
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
Mandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 953
Self-citationWischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
A family of human cdc2-related protein kinases.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., & Tsai, L. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 923
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
Cleveland, D. W., Hwo, S.-Y., & Kirschner, M. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90213-3 · Cited by 915 · cited 1×
“These structures were initially described in 1907 by Alois Alzheimer [18,19], but their major constituent was only identified in 1988 as a highly insoluble form of the microtubule-binding protein tau ([20,21]; reviewed in [22±25]).”
BackgroundThe cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820
Self-citationHoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., et al. (1999) · Nature Cell Biology · doi:10.1038/9035 · Cited by 809
Self-citationExploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Self-citationBiernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796
Self-citationβ-catenin: a key mediator of Wnt signaling
Willert, K., & Nusse, R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80068-3 · Cited by 753
Pavletich, N. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2640 · Cited by 744
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
Self-citationA brain-specific activator of cyclin-dependent kinase 5
Lew, J., Huang, Q.-Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., & Wang, J. H. (1994) · Nature · doi:10.1038/371423a0 · Cited by 579
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L.-H., Kwon, Y. T., Girault, J.-A., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 552
Self-citationEctopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543
Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos
He, X., Saint-Jeannet, J.-P., Woodgett, J. R., Varmus, H. E., & Dawid, I. B. (1995) · Nature · doi:10.1038/374617a0 · Cited by 490
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea, A., Harris, P. L. R., Webster, K. R., Wahl, A. F., & Smith, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 476
Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 469
Meijer, L., Thunnissen, A.-M., White, A., Garnier, M., Nikolic, M., Tsai, L.-H., Walter, J., Cleverley, K., Salinas, P., Wu, Y.-Z., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00063-6 · Cited by 454
Self-citationVincent, I., Jicha, G., Rosado, M., & Dickson, D. W. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03588.1997 · Cited by 444
Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal
Hetman, M., Cavanaugh, J. E., Kimelman, D., & Xia, Z. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02567.2000 · Cited by 440
Bidirectional Regulation of DARPP-32 Phosphorylation by Dopamine
Nishi, A., Snyder, G. L., & Greengard, P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08147.1997 · Cited by 424
Self-citationPresenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409
Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275
Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., & Worland, P. J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1742 · Cited by 345
Self-citationSchultz, C., Link, A., Leost, M., Zaharevitz, D. W., Gussio, R., Sausville, E. A., Meijer, L., & Kunick, C. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900570 · Cited by 334
Self-citationCyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation
Sielecki, T. M., Boylan, J. F., Benfield, P. A., & Trainor, G. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990256j · Cited by 323
Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
Muñoz-Montaño, J. R., Moreno, F. J., Avila, J., & Dı́az-Nido, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00688-1 · Cited by 322
Zheng‐Fischhöfer, Q., Biernat, J., Mandelkow, E., Illenberger, S., Godemann, R., & Mandelkow, E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520542.x · Cited by 321
Self-citationIllenberger, S., Zheng-Fischhöfer, Q., Preuss, U., Stamer, K., Baumann, K., Trinczek, B., Biernat, J., Godemann, R., Mandelkow, E.-M., & Mandelkow, E. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.6.1495 · Cited by 304
Self-citationLucas, F. R., Goold, R. G., Gordon-Weeks, P. R., & Salinas, P. C. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.10.1351 · Cited by 301
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 288
Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., & Yamaguchi, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00061-3 · Cited by 287
Paudel, H. K., Lew, J., Ali, Z., & Wang, J. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49492-1 · Cited by 285
Microtubule-Associated Protein Tau
Yen, S.-H., Nacharaju, P., Ko, L.-W., Kenessey, A., & Liu, W.-K. (1998) · Handbook of the Aging Brain · doi:10.1016/b978-012734610-6/50012-9 · Cited by 282
Zaharevitz, D. W., Gussio, R., Leost, M., Senderowicz, A. M., Lahusen, T. J., Kunick, C., Meijer, L., & Sausville, E. A. (1999) · PubMed · Cited by 278
Self-citationChang, Y.-T., Gray, N. S., Rosania, G. R., Sutherlin, D. P., Kwon, S., Norman, T. C., Sarohia, R., Leost, M., Meijer, L., & Schultz, P. G. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80048-9 · Cited by 268
Self-citationATP-site Directed Inhibitors of Cyclin-dependent Kinases
G ray, N., Detivaud, L., Doerig, C., & Meijer, L. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401152358 · Cited by 266
Self-citationCyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents
Park, D. S., Morris, E. J., Padmanabhan, J., Shelanski, M. L., Geller, H. M., & Greene, L. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.457 · Cited by 263
Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Kitagawa, M., Okabe, T., Ogino, H., Matsumoto, H., Suzuki‐Takahashi, I., Kokubo, T., Higashi, H., Saitoh, S., Taya, Y., & Yasuda, H. (1993) · PubMed · Cited by 257
Yamaguchi, H., Ishiguro, K., Uchida, T., Takashima, A., Lemere, C. A., & Imahori, K. (1996) · Acta Neuropathologica · doi:10.1007/s004010050513 · Cited by 253
Park, D. S., Farinelli, S. E., & Greene, L. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8161 · Cited by 250
Mitotic signaling by β‐amyloid causes neuronal death
COPANI, A., CONDORELLI, F., CARUSO, A., VANCHERI, C., SALA, A., STELLA, A. M. G., CANONICO, P. L., NICOLETTI, F., & SORTINO, M. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2225 · Cited by 245
Giovanni, A., Wirtz-Brugger, F., Keramaris, E., Slack, R., & Park, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19011 · Cited by 240
Progress in Cell Cycle Research
(1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7 · Cited by 237
Kobayashi, S., Ishiguro, K., Omori, A., Takamatsu, M., Arioka, M., Imahori, K., & Uchida, T. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80723-8 · Cited by 234
The Role of Glycogen Synthase Kinase 3β in Insulin-stimulated Glucose Metabolism
Summers, S. A., Kao, A. W., Kohn, A. D., Backus, G. S., Roth, R. A., Pessin, J. E., & Birnbaum, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17934 · Cited by 212
cAMP-Dependent Protein Kinase Phosphorylations on Tau in Alzheimer’s Disease
Jicha, G. A., Weaver, C., Lane, E., Vianna, C., Kress, Y., Rockwood, J., & Davies, P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07486.1999 · Cited by 206
The development and therapeutic potential of protein kinase inhibitors
Cohen, P. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80067-2 · Cited by 182
The Structure-Based Design of ATP-Site Directed Protein Kinase Inhibitors
Toledo, Lydon, N. B., & Elbaum, D. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401150028 · Cited by 176
GSK3β/shaggy mediates patterning along the animal-vegetal axis of the sea urchin embryo
Emily-Fenouil, F., Ghiglione, C., Lhomond, G., Lepage, T., & Gache, C. (1998) · Development · doi:10.1242/dev.125.13.2489 · Cited by 171
Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain
Lee, K.-Y., Clark, A. W., Rosales, J. L., Chapman, K., Fung, T., & Johnston, R. N. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00026-7 · Cited by 168
Lovestone, S., Davis, D. R., Webster, M.-T., Kaech, S., Brion, J., Matus, A. I., & Anderton, B. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00183-8 · Cited by 166
Maggirwar, S. B., Tong, N., Ramirez, S., Gelbard, H. A., & Dewhurst, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730578.x · Cited by 164
CDK inhibition and cancer therapy
Garrett, M. D., & Fattaey, A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80015-x · Cited by 163
Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
Sengupta, A., Wu, Q., Grundke-Iqbal, I., Iqbal, K., & Singh, T. J. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006883924775 · Cited by 160
Cohen, P. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0399 · Cited by 158 · cited 1×
“GSK-3 is involved in the WNT signaling pathway [9], cell cycle regulation [10,11], dorsoventral patterning during development [12,13], insulin action on glycogen synthesis [14,15], axonal outgrowth [16], HIV-1 Tat-mediated neurotoxicity [17], among others.”
BackgroundA New Molecular Link between the Fibrillar and Granulovacuolar Lesions of Alzheimer's Disease
Ghoshal, N., Smiley, J. F., DeMaggio, A. J., Hoekstra, M. F., Cochran, E. J., Binder, L. I., & Kuret, J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65219-4 · Cited by 151
Biernat, J., & Mandelkow, E.-M. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.3.727 · Cited by 149 · cited 1×
“To determine the effects of aminopurvalanol and alsterpaullone on tau phosphorylation, Sf9 cells infected with baculovirus expressing htau23 protein were treated 36 h post infection (when cells have already expressed levels of tau sufficient for the outgrowth of cell processes [83] with 20 mm inhibitors for 3 h before…”
MethodSelf-citationIshiguro, K., Kobayashi, S., Onion, A., Takamatsu, M., Yonekura, S., Anzai, K., Imahori, K., & Uchida, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80501-6 · Cited by 147
Hers, I., Tavaré, J. M., & Denton, R. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01389-7 · Cited by 144
Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation
Sharma, P., Sharma, M., Amin, N. D., Albers, R. W., & Pant, H. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11156 · Cited by 129
Godemann, R., Biernat, J., Mandelkow, E., & Mandelkow, E.-M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00741-3 · Cited by 110
Self-citationCaspase-Dependent Cdk Activity Is a Requisite Effector of Apoptotic Death Events
Harvey, K. J., Lukovic, D., & Ucker, D. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.1.59 · Cited by 102
Takahashi, M., Yasutake, K., & Tomizawa, K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02073.x · Cited by 100
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
Brownlees, J., Irving, N. G., Brion, J.-P., M. Gibb, B. J., Wagner, U., Woodgett, J., & J. Miller, C. C. (1997) · NeuroReport · doi:10.1097/00001756-199710200-00013 · Cited by 99
Properties and Potential Applications of Chemical Inhibitors of Cyclin-Dependent Kinases
Meijer, L., Leclerc, S., & Leost, M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00057-6 · Cited by 96
Self-citationTakahashi, M., Yasutake, K., & Tomizawa, K. (1999) · PubMed · Cited by 88
2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity
Kunick, C., Schultz, C., Lemcke, T., Zaharevitz, D. W., Gussio, R., Jalluri, R. K., Sausville, E. A., Leost, M., & Meijer, L. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00048-2 · Cited by 86
Self-citationAlzheimer's Disease and Related Disorders
Harik, S. I. (1990) · Neurology · doi:10.1212/wnl.40.1.195-b · Cited by 85
Phosphorylation of τ Protein by Casein Kinase‐1 Converts It to an Abnormal Alzheimer‐Like State
Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031420.x · Cited by 81
Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators
Tang, D., & Wang, J. H.-C. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_20 · Cited by 78
Wilkins, R. H., & Brody, I. A. (1969) · Archives of Neurology · doi:10.1001/archneur.1969.00480130123013 · Cited by 62
HUGHES, K., PULVERER, B. J., THEOCHAROUS, P., & WOODGETT, J. R. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb19860.x · Cited by 55
Abortive oncogeny and cell cycle-mediated events in Alzheimer disease
Raina, A. K., Zhu, X., Monteiro, M. J., Takeda, A., & Smith, M. A. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_20 · Cited by 35
Presenilins: Structural aspects and posttranslational events
Checler, F. (1999) · Molecular Neurobiology · doi:10.1007/bf02821716 · Cited by 27
Proteolysis by presenilins and the renaissance of tau
Haass, C., & Mandelkow, E. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01576-7 · Cited by 23
Self-citationTau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders
Larner, A. J. (1999) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.9.10.1359 · Cited by 11
Cited by
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 808
Self-citation
Metadata
- Authors
- Leost, M., Schultz, C., Link, A., Wu, Y., Biernat, J., Mandelkow, E., Bibb, J. A., Snyder, G. L., Greengard, P., Zaharevitz, D. W., Gussio, R., Senderowicz, A. M., Sausville, E. A., Kunick, C., & Meijer, L.
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 2000-10
- Volume
- 267
- Issue
- 19
- Pages
- 5983-5994
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2144508375
- Cited by
- 376
- References
- 92
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.